Literature DB >> 9184525

Tuberculosis screening at a syringe exchange program.

D C Perlman1, M P Perkins, N Solomon, L Kochems, D C Des Jarlais, D Paone.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9184525

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  9 in total

1.  Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

Authors:  D C Des Jarlais; D G Fisher; J C Newman; B N Trubatch; M Yancovitz; D Paone; D Perlman
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

Review 2.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

3.  Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program.

Authors:  D C Perlman; M N Gourevitch; C Trinh; N Salomon; L Horn; D C Des Jarlais
Journal:  J Urban Health       Date:  2001-09       Impact factor: 3.671

4.  Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.

Authors:  Elise D Riley; David Vlahov; Steven Huettner; Peter Beilenson; Margaret Bonds; Richard E Chaisson
Journal:  J Urban Health       Date:  2002-03       Impact factor: 3.671

5.  High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.

Authors:  R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

6.  Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.

Authors:  David C Perlman; Patricia Friedmann; Leslie Horn; Anne Nugent; Veronika Schoeb; Jeanne Carey; Nadim Salomon; Don C Des Jarlais
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

7.  The case for chronic disease management for addiction.

Authors:  Richard Saitz; Mary Jo Larson; Colleen Labelle; Jessica Richardson; Jeffrey H Samet
Journal:  J Addict Med       Date:  2008-06       Impact factor: 3.702

8.  Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers.

Authors:  Lauretta E Grau; Abbie Griffiths-Kundishora; Robert Heimer; Marguerite Hutcheson; Amy Nunn; Caitlin Towey; Thomas J Stopka
Journal:  Addict Sci Clin Pract       Date:  2017-10-02

9.  Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.

Authors:  Sarah Bowman; Lauretta E Grau; Merrill Singer; Greg Scott; Robert Heimer
Journal:  BMC Public Health       Date:  2014-08-09       Impact factor: 3.295
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.